Keywords: supergen, sells, nipent, rights, mayne, australia, pharma

Supergen sells US Nipent rights to Mayne

Article | 03 July 2006

Print This

Australia's Mayne Pharma and USA-based drugmaker SuperGen have signed a definitive agreement for the former to acquire the North American ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in